Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid

3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid
[CAS# 1357931-55-5]

List of Suppliers
Shanghai Forever Synthesis Co.,Ltd. China Inquire  
+86 (551) 6288-8437
+86 18096409024
sales@foreversyn.com
sales02@foreversyn.com
Skype Chat
QQ chat
Chemical distributor since 2013
chemBlink standard supplier since 2018
Dalton Pharma Services Canada Inquire  
+1 (416) 661-2102
chemist@dalton.com
Chemical manufacturer
Complete supplier list of 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid
Identification
Name 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid
Molecular Structure CAS # 1357931-55-5, 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid
Molecular Formula C17H20N4O5S
Molecular Weight 392.43
CAS Registry Number 1357931-55-5
EC Number 830-825-9
Properties
Solubility Very slightly soluble (0.67 g/L) (25 ºC), Calc.*
Density 1.48±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
Skin irritationSkin Irrit.2H315
SDS Available
Market Analysis Reports
List of Reports Available for 3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid
Related Products
[1,3-Dihydro-5-[(4-methyl-1-piperazinyl)methyl]-2H-isoindol-2-yl][2,4-dihydroxy-5-(1-methylethyl)phenyl]methanone hydrochloride  1,6-Dihydro-N-[4-(4-methyl-1-piperazinyl)-3'-(4-morpholinylmethyl)[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-3-pyridinecarboxamide  (3Z)-1,3-Dihydro-4-(4-methyl-1-piperazinyl)-3-(2-oxopropylidene)-2H-1,5-benzodiazepin-2-one  2,3-Dihydro-3-[(4-methyl-1-piperazinyl)phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester  7',8'-Dihydro-2'-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one  7',8'-Dihydro-2'-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one hydrochloride (1:2)  N-[(1S)-2-[[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide  (2R,3S)-N1-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide  2-[(1,5-Dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-2,3-dihydro-1,3,3-trimethyl-1H-indole-5-carboxylic acid methyl ester  1,6-Dihydro-2-methyl-6-oxo-1-phenyl-3-pyridinecarboxylic acid ethyl ester  3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonic acid ethyl ester  3-[6,7-Dihydro-1-(methyl-d3)-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-4-propoxybenzenesulfonamide  N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxamide  3,4-Dihydro-5-methyl-3-oxo-2-pyrazinecarboxamide  4,5-Dihydro-6-methyl-5-oxo-2-pyrazinecarboxylic acid  2,3-Dihydro-1-methyl-3-oxo-1H-pyrazole-4-carboxylic acid ethyl ester  2,5-Dihydro-2-methyl-5-oxo-1H-pyrazole-3-carboxylic acid methyl ester  6-(4,5-Dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)naphthalene-1,3-disulfonic acid  2,3-Dihydro-6-methyl-3-oxo-4-pyridazinecarboxylic acid ethyl ester  1,6-Dihydro-5-methyl-6-oxo-3-pyridinecarboxaldehyde